000 | 01975 a2200601 4500 | ||
---|---|---|---|
005 | 20250518025344.0 | ||
264 | 0 | _c20200520 | |
008 | 202005s 0 0 eng d | ||
022 | _a1945-7197 | ||
024 | 7 |
_a10.1210/jc.2019-00139 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHamblin, Peter S | |
245 | 0 | 0 |
_aSGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _c08 2019 |
||
300 |
_a3077-3087 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 |
_aDiabetic Ketoacidosis _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xadverse effects |
700 | 1 | _aWong, Rosemary | |
700 | 1 | _aEkinci, Elif I | |
700 | 1 | _aFourlanos, Spiros | |
700 | 1 | _aShah, Sonali | |
700 | 1 | _aJones, Alicia R | |
700 | 1 | _aHare, Matthew J L | |
700 | 1 | _aCalder, Genevieve L | |
700 | 1 | _aEpa, Dilan Seneviratne | |
700 | 1 | _aGeorge, Elizabeth M | |
700 | 1 | _aGiri, Rinky | |
700 | 1 | _aKotowicz, Mark A | |
700 | 1 | _aKyi, Mervyn | |
700 | 1 | _aLafontaine, Nicole | |
700 | 1 | _aMacIsaac, Richard J | |
700 | 1 | _aNolan, Brendan J | |
700 | 1 | _aO'Neal, David N | |
700 | 1 | _aRenouf, Debra | |
700 | 1 | _aVaradarajan, Suresh | |
700 | 1 | _aWong, Jennifer | |
700 | 1 | _aXu, Sylvia | |
700 | 1 | _aBach, Leon A | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 104 _gno. 8 _gp. 3077-3087 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2019-00139 _zAvailable from publisher's website |
999 |
_c29442288 _d29442288 |